Portfolio company
Tripep AB
Country not known yet
Raised
Not known yet
Latest stage
Not known yet
Rounds recorded
Not known yet
Backed by
1 investor
Sectors
About
This pharmaceutical company develops therapies and DNA vaccines for chronic viral infections, including hepatitis C, to improve patient outcomes in the healthcare sector.
SourceFunding history · 0
No rounds recorded yet. The agent looks for them over time.
Similar companies
CePep AB
This company develops cell-penetrating peptide delivery platforms for nucleic acid based therapeutics and drug discovery applications within the biotechnology and pharmaceutical industries.
Oncopeptides AB
This biotech company develops targeted therapies for patients with difficult-to-treat hematological diseases, specifically focusing on multiple myeloma treatments.
Pharmexa A/S
This company develops active immunotherapy and peptide vaccines for patients with cancer, chronic illnesses, and infectious diseases.
Alzinova
This biopharmaceutical company develops immunotherapies and vaccines targeting toxic amyloid-beta oligomers to treat and prevent Alzheimer's disease for patients worldwide.
Cloverleaf Bio
This company develops engineered transfer RNA therapeutics to treat various cancers, including hepatocellular carcinoma and colorectal cancer, for the healthcare and pharmaceutical industries.
Atea Pharmaceuticals
This biopharmaceutical company develops oral antiviral therapies to treat patients with serious viral infections, including hepatitis C and hepatitis E.
Cytos Biotechnology AG
This biopharmaceutical company develops immunotherapies and vaccines targeting chronic and infectious diseases for patients and healthcare providers.
Hookipa Pharma
This biopharmaceutical company develops arenavirus-based immunotherapies to treat infectious diseases and cancers for patients and healthcare providers.
